Anti-Regulatory T Cell Vaccines in Immunotherapy: Focusing on FoxP3 as Target

Human Vaccines and Immunotherapeutics- United States

doi 10.1080/21645515.2018.1545625

Full Text

Abstract

Available in

Date

Authors

Publisher

Informa UK Limited

Related search

Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Foxp3 Expression in T Regulatory Cells and Other Cell Lineages

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2014English

Development of Foxp3+ Regulatory T Cell: Epigenetics and More…

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Genome-Wide Identification of Human FOXP3 Target Genes in Natural Regulatory T Cells

Journal of Immunology
AllergyImmunology
2010English

CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection

Frontiers in Immunology
AllergyImmunology
2013English

CD4+CD25+FOXP3+ Regulatory T Cells in Allogeneic Hematopoietic Cell Transplantation

Journal of Tropical Life Science
2012English

The Control of CD4+CD25+Foxp3+ Regulatory T Cell Survival

Biology Direct
EvolutionEcologyGeneticsMolecular BiologyBiochemistryApplied MathematicsSystematicsSimulationImmunologyBehaviorBiological SciencesAgriculturalModeling
2008English

TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy

2019English

Anti-Il6r Treatment Acts on CD4+ FoxP3+ Regulatory T Cells in a Model of Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy